Introduction: Diffusion-weighted MRI (DWI) contributes to N staging of rectal cancers and diagnosis of colorectal liver metastases (CLM). About 15% of CLM patients have loco-regional lymph node (LN) metastases that impact prognosis and treatment strategy. This retrospective study is the first one to evaluate quantitative ADC measurement as a tool to identify metastatic LNs in patients with liver metastases from colorectal cancer. Methods: All consecutive patients undergoing surgery for CLM between 2008 and 2015 were considered. Inclusion criteria were: intraoperative retrieval of at least one LN; LN >= 5 mm; DWI performed <= 2 months before surgery. The ADC and ADC(ratio) (ADC(LN)/ADC(CLM)) were computed by two radiologists for all the LNs. Results: Among 555 patients operated for CLM, 32 met the inclusion criteria. Fifty-six LNs were analyzed and 28 were metastatic. ADC and ADC(ratio) in metastatic LNs were lower than in benign LNs (ADC 1.37 vs. 1.83 x 10(-3) mm(2)/s, p < 0.001; ADC(ratio) = 1.26 vs. 1.73, p < 0.001). The optimal cut-off value for ADC was 1.48 x 10(-3) mm(2)/s (AUC = 0.85, p < 0.001, sensitivity/specificity/accuracy 79%/93%/86% in per LN-analysis and 94%/86%/91% in per-patient analysis). The optimal cut-off for ADC(ratio) was 1.15 (AUC = 0.80, p < 0.001, sensitivity/specificity/accuracy 693%/81% and 76%,93%/84%). Excellent inter- and intra-operators' agreements were observed. Conclusion: In patients with CLM, ADC values < 1.48 x 10(-3) mm(2)/s can be postulated as a cut-off to distinguish metastatic LNs. (C) 2018 Published by Elsevier Ltd.

Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases

Vigano L;Donadon M;Procopio F;Chiti A;Torzilli G
2019

Abstract

Introduction: Diffusion-weighted MRI (DWI) contributes to N staging of rectal cancers and diagnosis of colorectal liver metastases (CLM). About 15% of CLM patients have loco-regional lymph node (LN) metastases that impact prognosis and treatment strategy. This retrospective study is the first one to evaluate quantitative ADC measurement as a tool to identify metastatic LNs in patients with liver metastases from colorectal cancer. Methods: All consecutive patients undergoing surgery for CLM between 2008 and 2015 were considered. Inclusion criteria were: intraoperative retrieval of at least one LN; LN >= 5 mm; DWI performed <= 2 months before surgery. The ADC and ADC(ratio) (ADC(LN)/ADC(CLM)) were computed by two radiologists for all the LNs. Results: Among 555 patients operated for CLM, 32 met the inclusion criteria. Fifty-six LNs were analyzed and 28 were metastatic. ADC and ADC(ratio) in metastatic LNs were lower than in benign LNs (ADC 1.37 vs. 1.83 x 10(-3) mm(2)/s, p < 0.001; ADC(ratio) = 1.26 vs. 1.73, p < 0.001). The optimal cut-off value for ADC was 1.48 x 10(-3) mm(2)/s (AUC = 0.85, p < 0.001, sensitivity/specificity/accuracy 79%/93%/86% in per LN-analysis and 94%/86%/91% in per-patient analysis). The optimal cut-off for ADC(ratio) was 1.15 (AUC = 0.80, p < 0.001, sensitivity/specificity/accuracy 693%/81% and 76%,93%/84%). Excellent inter- and intra-operators' agreements were observed. Conclusion: In patients with CLM, ADC values < 1.48 x 10(-3) mm(2)/s can be postulated as a cut-off to distinguish metastatic LNs. (C) 2018 Published by Elsevier Ltd.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/5310
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact